These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
345 related articles for article (PubMed ID: 33250518)
1. Hypoxia induces sorafenib resistance mediated by autophagy via activating FOXO3a in hepatocellular carcinoma. Liang C; Dong Z; Cai X; Shen J; Xu Y; Zhang M; Li H; Yu W; Chen W Cell Death Dis; 2020 Nov; 11(11):1017. PubMed ID: 33250518 [TBL] [Abstract][Full Text] [Related]
2. MiRNA-124-3p.1 sensitizes hepatocellular carcinoma cells to sorafenib by regulating FOXO3a by targeting AKT2 and SIRT1. Dong ZB; Wu HM; He YC; Huang ZT; Weng YH; Li H; Liang C; Yu WM; Chen W Cell Death Dis; 2022 Jan; 13(1):35. PubMed ID: 35013144 [TBL] [Abstract][Full Text] [Related]
3. RNA m Lin Z; Niu Y; Wan A; Chen D; Liang H; Chen X; Sun L; Zhan S; Chen L; Cheng C; Zhang X; Bu X; He W; Wan G EMBO J; 2020 Jun; 39(12):e103181. PubMed ID: 32368828 [TBL] [Abstract][Full Text] [Related]
4. Autophagy-Related Chemoprotection against Sorafenib in Human Hepatocarcinoma: Role of FOXO3 Upregulation and Modulation by Regorafenib. Fondevila F; Méndez-Blanco C; Fernández-Palanca P; Payo-Serafín T; van Pelt J; Verslype C; González-Gallego J; Mauriz JL Int J Mol Sci; 2021 Oct; 22(21):. PubMed ID: 34769197 [TBL] [Abstract][Full Text] [Related]
5. MiR-21 mediates sorafenib resistance of hepatocellular carcinoma cells by inhibiting autophagy via the PTEN/Akt pathway. He C; Dong X; Zhai B; Jiang X; Dong D; Li B; Jiang H; Xu S; Sun X Oncotarget; 2015 Oct; 6(30):28867-81. PubMed ID: 26311740 [TBL] [Abstract][Full Text] [Related]
6. CD24 regulates sorafenib resistance via activating autophagy in hepatocellular carcinoma. Lu S; Yao Y; Xu G; Zhou C; Zhang Y; Sun J; Jiang R; Shao Q; Chen Y Cell Death Dis; 2018 May; 9(6):646. PubMed ID: 29844385 [TBL] [Abstract][Full Text] [Related]
7. Hypoxia-mediated sorafenib resistance can be overcome by EF24 through Von Hippel-Lindau tumor suppressor-dependent HIF-1α inhibition in hepatocellular carcinoma. Liang Y; Zheng T; Song R; Wang J; Yin D; Wang L; Liu H; Tian L; Fang X; Meng X; Jiang H; Liu J; Liu L Hepatology; 2013 May; 57(5):1847-57. PubMed ID: 23299930 [TBL] [Abstract][Full Text] [Related]
8. Genome-scale CRISPRa screening identifies MTX1 as a contributor for sorafenib resistance in hepatocellular carcinoma by augmenting autophagy. Li L; Yu S; Hu Q; Hai Y; Li Y Int J Biol Sci; 2021; 17(12):3133-3144. PubMed ID: 34421355 [TBL] [Abstract][Full Text] [Related]
9. miR-223 overexpression inhibits doxorubicin-induced autophagy by targeting FOXO3a and reverses chemoresistance in hepatocellular carcinoma cells. Zhou Y; Chen E; Tang Y; Mao J; Shen J; Zheng X; Xie S; Zhang S; Wu Y; Liu H; Zhi X; Ma T; Ni H; Chen J; Chai K; Chen W Cell Death Dis; 2019 Nov; 10(11):843. PubMed ID: 31695022 [TBL] [Abstract][Full Text] [Related]
10. miR-541 potentiates the response of human hepatocellular carcinoma to sorafenib treatment by inhibiting autophagy. Xu WP; Liu JP; Feng JF; Zhu CP; Yang Y; Zhou WP; Ding J; Huang CK; Cui YL; Ding CH; Zhang X; Lu B; Xie WF Gut; 2020 Jul; 69(7):1309-1321. PubMed ID: 31727683 [TBL] [Abstract][Full Text] [Related]
11. Salinomycin decreases doxorubicin resistance in hepatocellular carcinoma cells by inhibiting the β-catenin/TCF complex association via FOXO3a activation. Zhou Y; Liang C; Xue F; Chen W; Zhi X; Feng X; Bai X; Liang T Oncotarget; 2015 Apr; 6(12):10350-65. PubMed ID: 25871400 [TBL] [Abstract][Full Text] [Related]
13. Vaccinia-related kinase 2 blunts sorafenib's efficacy against hepatocellular carcinoma by disturbing the apoptosis-autophagy balance. Chen S; Du Y; Xu B; Li Q; Yang L; Jiang Z; Zeng Z; Chen L Oncogene; 2021 May; 40(19):3378-3393. PubMed ID: 33875785 [TBL] [Abstract][Full Text] [Related]
14. Autophagy modulation attenuates sorafenib resistance in HCC induced in rats. Elleithi Y; El-Gayar A; Amin MN Cell Death Dis; 2024 Aug; 15(8):595. PubMed ID: 39152108 [TBL] [Abstract][Full Text] [Related]
15. Inhibition of Akt reverses the acquired resistance to sorafenib by switching protective autophagy to autophagic cell death in hepatocellular carcinoma. Zhai B; Hu F; Jiang X; Xu J; Zhao D; Liu B; Pan S; Dong X; Tan G; Wei Z; Qiao H; Jiang H; Sun X Mol Cancer Ther; 2014 Jun; 13(6):1589-98. PubMed ID: 24705351 [TBL] [Abstract][Full Text] [Related]
16. MiR-25 enhances autophagy and promotes sorafenib resistance of hepatocellular carcinoma via targeting FBXW7. Feng X; Zou B; Nan T; Zheng X; Zheng L; Lan J; Chen W; Yu J Int J Med Sci; 2022; 19(2):257-266. PubMed ID: 35165511 [TBL] [Abstract][Full Text] [Related]
17. Cholesterol sensor SCAP contributes to sorafenib resistance by regulating autophagy in hepatocellular carcinoma. Li D; Yao Y; Rao Y; Huang X; Wei L; You Z; Zheng G; Hou X; Su Y; Varghese Z; Moorhead JF; Chen Y; Ruan XZ J Exp Clin Cancer Res; 2022 Mar; 41(1):116. PubMed ID: 35354475 [TBL] [Abstract][Full Text] [Related]
18. TARBP2-mediated destabilization of Nanog overcomes sorafenib resistance in hepatocellular carcinoma. Lai HH; Li CW; Hong CC; Sun HY; Chiu CF; Ou DL; Chen PS Mol Oncol; 2019 Apr; 13(4):928-945. PubMed ID: 30657254 [TBL] [Abstract][Full Text] [Related]
19. Rage induces hepatocellular carcinoma proliferation and sorafenib resistance by modulating autophagy. Li J; Wu PW; Zhou Y; Dai B; Zhang PF; Zhang YH; Liu Y; Shi XL Cell Death Dis; 2018 Feb; 9(2):225. PubMed ID: 29445087 [TBL] [Abstract][Full Text] [Related]
20. Multiple Roles of Autophagy in the Sorafenib Resistance of Hepatocellular Carcinoma. Sun T; Liu H; Ming L Cell Physiol Biochem; 2017; 44(2):716-727. PubMed ID: 29169150 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]